Discussions ranged from spatial proteomic comparisons of tauopathies, microvascular contributions to pathological progression of tauopathies, mechanisms of trans‐synaptic propagation of tau pathology, and the vulnerability profile of glutamatergic presynaptic terminals. This evidence concerns the gene MAPT and tauopathy.